Read + Share
Amedeo Smart
Independent Medical Education
Landi A. Duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk. Int J Cardiol 2023;378:10.PMID: 36812988
Email
LinkedIn
Facebook
Twitter
Privacy Policy